BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12288098)

  • 21. Emergency contraception: a second chance at preventing adolescent unintended pregnancy.
    Gold MA
    Curr Opin Pediatr; 1997 Aug; 9(4):300-9. PubMed ID: 9300185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized instructions urged for OCs.
    FDA Med Bull; 1992 Sep; 22(2):6-7. PubMed ID: 12343902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labeling has caused "incredible confusion".
    Contracept Technol Update; 1995 Apr; 16(4):49-51. PubMed ID: 12347027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical groups and health care providers petition FDA to relabel six oral contraceptives as "morning after pills".
    Reprod Freedom News; 1994 Dec; 3(21):4-5. PubMed ID: 12288091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency contraception use up -- new ECP arrives.
    Contracept Technol Update; 1999 Sep; 20(9):108-9. PubMed ID: 12290378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using oral contraceptives correctly: progress on package instructions.
    Finger WR
    Netw Res Triangle Park N C; 1991 Sep; 12(2):14-7, 27. PubMed ID: 12284274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postcoital contraception underrecognized and underutilized.
    Demarco JJ
    Female Patient; 1992 Jun; 17(6):24, 26. PubMed ID: 12287765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of post-coital contraception in Finland is increasing.
    Lahteenmaki P; Suhonen S; Elomaa K
    Plan Parent Eur; 1995 Aug; 24(2):13-4. PubMed ID: 12290796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ortho markets first FDA-approved triphasic pill.
    Contracept Technol Update; 1984 Jun; 5(6):69-71. PubMed ID: 12313082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Providers make EC readily available.
    Contracept Technol Update; 2000 Sep; 21(9):112-3. PubMed ID: 12296244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revised oral contraceptive labeling: FDA approves recommendation allowing delay of pelvic exam.
    Contracept Rep; 1993 Nov; 4(5):4-7. PubMed ID: 12287403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct-to-consumer advertising affects provider / patient relationship.
    Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Despite court ruling, experts insist spermicides are safe.
    Contracept Technol Update; 1985 Mar; 6(3):37-9. PubMed ID: 12266719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "EC to go" takes off at Maryland sites.
    Contracept Technol Update; 2000 Mar; 21(3):33-5. PubMed ID: 12349550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA: polyurethane condom carries "extremely misleading" label. Federal agency allows distribution for public health's sake.
    Contracept Technol Update; 1995 Feb; 16(2):17-20. PubMed ID: 12290714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contraceptive sponge discontinued.
    Contracept Rep; 1995 Mar; 6(1):14. PubMed ID: 12288786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency contraception (post-coital Contraception).
    Pham A
    J Okla State Med Assoc; 2002 Jun; 95(6):371-4. PubMed ID: 12080896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraceptive technologies: how much choice do we really have?
    Fishel J
    ZPG Report; 1997; 29(2):4-6. PubMed ID: 12293118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New labeling to provide information about contraceptives and STDs.
    FDA Med Bull; 1993 Jun; 23(2):4-5. PubMed ID: 12286898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.